Intradermal influenza vaccine
The invention relates to virosome-based influenza vaccines for the manufacture of medicaments that are administered intradermally in humans. The invention provides (trivalent) compositions comprising low doses of hemagglutinin (HA) antigen in a virosomal preparation that fulfill the immune response...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
30.01.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to virosome-based influenza vaccines for the manufacture of medicaments that are administered intradermally in humans. The invention provides (trivalent) compositions comprising low doses of hemagglutinin (HA) antigen in a virosomal preparation that fulfill the immune response standards with respect to seroconversion rates, GMT-fold increase and protection rates, for use in vaccination set-ups. |
---|---|
Bibliography: | Application Number: AU20080263970 |